Indications
Therapeutic Asset Ratings
9,920 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Radiprodil
Nervous System Disorder
GRIN Therapeutics, Inc.
P1
CC
(43)
Raltitrexed
Peritoneal Carcinomatosis
Second Affiliated Hospital, School of Medicine, Zhejiang University
P1
CC
(43)
rd13-02 cell infusion
Lymphoid Neoplasm
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
P1
CC
(43)
Rebecsinib
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
Aspera Biomedicines, Inc.
P1
CC
(43)
Recombinant Flt3 Ligand
Basal Cell Carcinoma
University of Southern California
P1
CC
(43)
Recombinant Flt3 Ligand
Bone Sarcoma
University of Southern California
P1
CC
(43)
Recombinant Fully Human Igg1 Kappa Anti-Tigit Monoclonal Antibody Eos-448
Plasma Cell Myeloma
iTeos Therapeutics
P1
CC
(43)
Recombinant Human Hyaluronidase
Non-Hodgkin Lymphoma
Thomas Jefferson University
P1
CC
(43)
Recombinant Human Il-21-Expressing Oncolytic Vaccinia Virus
Cancer
Hangzhou Converd Co., Ltd.
P1
CC
(43)
Recombinant Humanized Bispecific Monoclonal Antibody Mbs301
Metastatic Malignant Neoplasm
Beijing Mabworks Biotech Co., Ltd.
P1
CC
(43)
Recombinant Humanized Monoclonal Antibody Mil95
Cancer
Beijing Mabworks Biotech Co., Ltd.
P1
CC
(43)
Recombinant Nv-A01 Adenovirus
Glioblastoma
First Affiliated Hospital of Wannan Medical College
P1
CC
(43)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
Histiocytic And Dendritic Cell Neoplasm
Mayo Clinic
P1
CC
(43)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
Acute Myeloid Leukemia
Mayo Clinic
P1
CC
(43)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
Angioimmunoblastic T-Cell Lymphoma
Mayo Clinic
P1
CC
(43)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
Plasma Cell Myeloma
Mayo Clinic
P1
CC
(43)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Mayo Clinic
P1
CC
(43)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
T-Cell Non-Hodgkin Lymphoma
Mayo Clinic
P1
CC
(43)
Regn5093-M114
Non-Small Cell Lung Carcinoma
Regeneron Pharmaceuticals
P1
CC
(43)
Regorafenib
Myelodysplastic Syndrome
City of Hope Medical Center
P1
CC
(43)
Relatlimab
Castration-Resistant Prostate Carcinoma
Exelixis
P1
CC
(43)
Remzistotug
Neoplasm
GlaxoSmithKline
P1
CC
(43)
Renvastinib
Cancer
Shanghai Junshi Bioscience Co., Ltd.
P1
CC
(43)
Repaglinide
Obesity Disorder
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
P1
CC
(43)
Re-Stimulated Tumor-Infiltrating Lymphocytes
Ovarian Serous Adenocarcinoma
University Health Network, Toronto
P1
CC
(43)
Showing 4026 to 4050 of 9,920 assets
Previous
Page 162 of 397
Next
